do glp-1 agonists have cardiovascular benefit Frontiers Discover the Game-Changing Benefits of

Zaharia, O

Abdelmalek, J

The Effect of Adiponectin in the Pathogenesis of Non-Alcoholic Fatty Liver Disease (NAFLD) and the Potential Role of Polyphenols in the Modulation of Adiponectin Signaling

Clinical studies have shown that these medications reduce glucose levels in people with diabetes without the problems of weight gain or risk of low glucose associated with some other diabetes treatments

[DOI] [PMC free article] [PubMed] [Google Scholar] 83.Radwan RM, Lee YA, Kotecha P, Wright DR, Hernandez I, Ramon R, et al

3 These adverse effects occur due to delayed gastric emptying, which prolongs satiety but can lead to discomfort